Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Misund
Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
Bone Morphogenetic Protein-9 Suppresses Growth of Myeloma Cells by Signaling Through ALK2 but Is Inhibited by Endoglin
Blood Cancer Journal
Oncology
Hematology
Related publications
Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Curcumin in Combination With Bortezomib Synergistically Induced Apoptosis in Human Multiple Myeloma U266 Cells
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics
Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma
Core Evidence
Medicine
Reviews
References
Pharmacology
Signaling Mechanisms of Bortezomib in TRAF3-deficient Mouse B Lymphoma and Human Multiple Myeloma Cells
Leukemia Research
Cancer Research
Oncology
Hematology
Blood Distribution of Bortezomib and Its Kinetics in Multiple Myeloma Patients
Clinical Biochemistry
Medicine
Clinical Biochemistry
Depletion of Intracellular Glutathione and Increased Lipid Peroxidation Mediate Cytotoxicity of Hematite Nanoparticles in MRC-5 Cells.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
Seminars in Hematology
Hematology